CAI
Clinical Asset Index
by VOS Supply Group
Verify
Sign inVerify

Drug acquisition-cost intelligence

For pharmacy & clinic buyers: the historical pharmacy acquisition-cost trend (NADAC), generic-equivalent cost comparison, and Medicare Part D coverage. NADAC is what pharmacies pay — an acquisition cost, not a retail or cash price (for consumer cash prices, use GoodRx or your plan).

Source: CMS NADAC · latest effective 2026-06-03 · methodology. Drug-pricing intelligence, not medical advice and not the price you’ll pay at a pharmacy.

💸 Biggest brand→generic savings →
Where switching to the generic cuts acquisition cost most.
⚠ Drugs currently in shortage →
FDA-reported shortages with acquisition cost + generic options.
Browse by therapeutic class
Corticosteroids 98Antibiotics 78Adrenergic and dopaminergic agents 35Antiinfectives and antiseptics for local oral treatment 31Anilides 27Antiinflammatory preparations, non-steroids for topical use 24Electrolyte solutions 24Antihistamines for topical use 20Antiinfectives 20Acetic acid derivatives and related substances 19Biguanides 19Angiotensin II receptor blockers (ARBs), plain 17Amides 16Beta blocking agents, selective 15Antiinflammatory agents, non-steroids 14Beta blocking agents 14Corticosteroids, plain 14Other antidepressants 14Other dermatologicals 14Anticholinergics 13Drugs for urinary frequency and incontinence 13Estren derivatives 13Other antihistamines for systemic use 13Selective beta-2-adrenoreceptor agonists 13Enemas 12Estrogens 12Muscle relaxants 123-oxoandrosten (4) derivatives 11ACE inhibitors, plain 11Anticholinesterases 11Antidotes 11Centrally acting sympathomimetics 11Proton pump inhibitors 11Antivirals for treatment of HIV infections, combinations 10Natural opium alkaloids 10Agents for dermatitis, excluding corticosteroids 9
60 shown · 2,272 drugs with real acquisition-cost history
Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate · Centrally acting sympathomimetics · Part D$1.93/EA acq · 11wkAll Day Allergycetirizine · Other antiallergics · Part D$0.0215/ML acq · 10wkAmbienzolpidem · Benzodiazepine related drugs · Part D$0.0339/EA acq · 10wkAMLODIPINE BESYLATE 10 mgamlodipine · Dihydropyridine derivatives · Part D$0.0114/EA acq · 10wkBRILINTAticagrelor · Platelet aggregation inhibitors excl. heparin · Part D$0.2912/EA acq · 10wkENTRESTOsacubitril · Angiotensin II receptor blockers (ARBs), other combinations · Part D$0.5498/EA acq · 10wkhaloperidol decanoatehaloperidol · Butyrophenone derivatives · Part D$13.25/ML acq · 10wkKLOR-CONpotassium chloride · Electrolyte solutions · Part D$0.0882/EA acq · 10wkLyricapregabalin · Gabapentinoids · Part D$0.0440/EA acq · 10wkUrea 40%urea · Solutions producing osmotic diuresis$0.6565/GM acq · 10wkVenlafaxine Hydrochloridevenlafaxine · Other antidepressants · Part D$0.2639/EA acq · 10wkViagrasildenafil · Drugs used in erectile dysfunction$83.67/EA acq · 10wkAbsoricaisotretinoin · Retinoids for topical use in acne · Part D$2.18/EA acq · 9wkAmlodipine and Olmesartan Medoxomilamlodipine · Angiotensin II receptor blockers (ARBs), plain · Part D$0.2953/EA acq · 9wkArixtrafondaparinux · Other antithrombotic agents · Part D$43.37/ML acq · 9wkBenicar HCTolmesartan · Angiotensin II receptor blockers (ARBs), plain · Part D$0.2331/EA acq · 9wkbupropion hydrochloride SRbupropion · Other antidepressants · Part D$0.1084/EA acq · 9wkceftriaxoneceftriaxone · Third-generation cephalosporins · Part D$1.32/EA acq · 9wkCycloSPORINE, Modfiedcyclosporine · Other ophthalmologicals · Part D$0.7177/EA acq · 9wkDaliresproflumilast · Other antipsoriatics for topical use · Part D$1.95/EA acq · 9wkDexamethasonedexamethasone · Corticosteroids · Part D$0.1989/ML acq · 9wkDiclofenac Potassiumdiclofenac · Antiinflammatory agents, non-steroids · Part D$4.41/EA acq · 9wkEMENDaprepitant · Other antiemetics · Part D$63.45/EA acq · 9wkequate mucus dguaifenesin · Sympathomimetics$0.3649/EA acq · 9wkhydromorphone hydrochloridehydromorphone · Natural opium alkaloids · Part D$9.82/EA acq · 9wkketorolac tromethamineketorolac · Acetic acid derivatives and related substances$0.7644/ML acq · 9wkLatudalurasidone · Indole derivatives · Part D$0.3091/EA acq · 9wkmorphine sulfatemorphine · Natural opium alkaloids · Part D$2.86/EA acq · 9wkNaloxone Hydrochloridenaloxone · Peripheral opioid receptor antagonists$17.66/EA acq · 9wkNitrostatnitroglycerin · Muscle relaxants · Part D$0.0815/EA acq · 9wkOLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDEamlodipine · Angiotensin II receptor blockers (ARBs), plain · Part D$1.23/EA acq · 9wktrazodone hydrochloridetrazodone · Other antidepressants · Part D$0.0503/EA acq · 9wkAbsolut Skin Corticosoothe Anti-Itchhydrocortisone · Corticosteroids · Part D$0.0627/GM acq · 8wkAcamprosate Calciumacamprosate · Drugs used in alcohol dependence · Part D$0.5871/EA acq · 8wkacetaminophen and codeine phosphateacetaminophen · Anilides · Part D$0.2144/EA acq · 8wkacetylcysteineacetylcysteine · Antidotes · Part D$2.37/ML acq · 8wkACTINEL Diabeticdextromethorphan · Expectorants$0.0110/ML acq · 8wkADMELOGinsulin lispro · Insulins and analogues for injection, intermediate-acting · Part D$10.17/ML acq · 8wkadult low dose aspirinaspirin · Other agents for local oral treatment$0.0144/EA acq · 8wkAlclometasone dipropionatealclometasone · Corticosteroids, moderately potent (group II) · Part D$0.7726/GM acq · 8wkAmbien CRzolpidem · Benzodiazepine related drugs · Part D$0.1161/EA acq · 8wkAMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDEamlodipine · Angiotensin II receptor blockers (ARBs), plain · Part D$6.56/EA acq · 8wkAMRIXcyclobenzaprine · Other centrally acting agents · Part D$1.10/EA acq · 8wkAndroGeltestosterone · 3-oxoandrosten (4) derivatives · Part D$0.6567/GM acq · 8wkARANESPdarbepoetin alfa · Other antianemic preparations$752.44/ML acq · 8wkAzilectrasagiline · Monoamine oxidase B inhibitors · Part D$0.8968/EA acq · 8wkbaclofenbaclofen · Other centrally acting agents · Part D$0.0556/EA acq · 8wkBenicarolmesartan · Angiotensin II receptor blockers (ARBs), plain · Part D$0.0780/EA acq · 8wkBliss GVSglycerin · Enemas$0.1115/EA acq · 8wkbuPropion Hydrochloride XLbupropion · Other antidepressants · Part D$0.0790/EA acq · 8wkCaduetamlodipine · Dihydropyridine derivatives · Part D$1.41/EA acq · 8wkcarbidopa, levodopa and entacaponecarbidopa · Other dopaminergic agents · Part D$0.6844/EA acq · 8wkCardizemdiltiazem · Benzothiazepine derivatives · Part D$0.0689/EA acq · 8wkCELEBREXcelecoxib · Coxibs · Part D$0.0835/EA acq · 8wkClobetasol Propionate (emollient)clobetasol · Corticosteroids, plain · Part D$0.5899/GM acq · 8wkCorlanorivabradine · Other cardiac preparations · Part D$0.7829/EA acq · 8wkcyanocobalaminvitamin B12 · Vitamin B12 (cyanocobalamin and analogues)$1.50/ML acq · 8wkCytomelliothyronine · Thyroid hormones · Part D$0.3130/EA acq · 8wkDapsone 100 mgdapsone · Other anti-acne preparations for topical use · Part D$0.8119/EA acq · 8wkDicyclomine hydrochloridedicyclomine · Synthetic anticholinergics, esters with tertiary amino group · Part D$0.0761/EA acq · 8wk
Clinical Asset Index
by VOS Supply Group

Observed-listing market intelligence for used clinical, dental, optometry, and lab equipment.

Product
DealsEquipment LibraryValuation ReportsDrug Costs (NADAC)Liquidation RadarVerify a ListingReportsData & CoverageBlog
Trust
AboutContactMethodologyAffiliate DisclosureData CorrectionsTerms of UsePrivacy Policy
Regulatory
AccessGUDID Device Search →
openFDA Device Recalls →
MAUDE Adverse Events →

Clinical Asset Index provides observed market intelligence — not an appraisal, not medical or regulatory advice. Always verify device condition, service history, regulatory status, and seller claims before purchase.

Independent of, and not endorsed, sponsored, certified, or authorized by — and not an agent of — any marketplace, manufacturer, or source. Market Index values are estimates based on observed listing data and do not represent appraisals or guaranteed sale prices.

Affiliate disclosure: CAI may earn a commission from some outbound marketplace links (eBay Partner Network). This does not influence which devices are tracked, the comps shown, the medians/tiers computed, or which listings appear in the deal feeds. See our disclosure for the full statement.

© 2026 V.O.S Supply Group LLC. All rights reserved.